Reply To: US Weekly IPO and SPAC Monitor: Edtech QuantaSing, Psychotropics Lucy Scientific Discovery


First Light Acquisition Group (FLAG) and Calidi Biotherapeutics have entered into a definitive merger agreement to create a public company focused on developing oncolytic viral therapies with stem cell-based delivery platforms to treat a wide range of cancers with significant unmet needs